We are not a peptide retailer.
A clear statement of what Peptide Authority is, what it is not, and what we will never do — because anyone reading our safety and legal content deserves to know where the money comes from.
What we are
- • An independent educational publisher about peptide research, UK law, and safety.
- • Run by an editorial team working against documented review process roles.
- • Funded primarily by general site monetisation and one disclosed affiliate relationship.
What we are not
- • A peptide retailer.
- • A clinic, prescriber, or telehealth provider.
- • A pharmacy or medicines wholesaler.
- • A medical, legal, or anti-doping adviser.
- • A ranking site or 'best peptide shop' directory.
- • A sourcing guide for unlicensed or grey-market products.
The one affiliate relationship we have
Peptide Authority earns a commission when readers buy from Peptide Barn, a research peptide retailer, via an affiliate link. We disclose this relationship wherever it appears on the site. The affiliate retailer has no influence over evidence grading, safety wording, regulatory framing, or which peptides we cover.
Full detail in our conflict of interest policy, including the editorial firewall rules we apply to keep affiliate revenue away from editorial decisions.
What we will never do
- • Recommend specific sellers (beyond our single disclosed affiliate, see below).
- • Compare suppliers by price, shipping, or 'reliability' for grey-market peptides.
- • Tell readers how to import peptides, evade customs, or split orders.
- • Tell readers which compounding pharmacies will fill unlicensed orders.
- • Tell readers how to dose, reconstitute, inject, cycle, or stack peptides.
- • Tell readers how to defeat drug-testing or anti-doping programmes.
- • Frame unlicensed peptides as approved treatments, cures, or repairs.
Why this position matters
Three of the biggest UK peptide safety issues are counterfeit weight-loss pens, unregulated online sellers, and clinics marketing unlicensed compounds as treatments. A publisher that helps readers understand those risks should not also be the one steering them toward grey-market purchases.
That is why our safety pages, legal pages, GLP-1 content, and prescription-only medicine content do not carry affiliate links. The affiliate relationship is confined to research peptide profiles where readers are already comparing retailers and deserve a transparently disclosed option rather than no information at all.
If we ever feel the affiliate relationship is shaping editorial decisions, we will either rewrite the policy or end the relationship. The corrections policy gives readers a documented route to flag concerns.
If you are looking for safer information
- Safety Centre — counterfeit pens, online seller red flags, clinic claim red flags, athlete anti-doping, talking to your doctor.
- UK Law hub — plain-English summaries of UK peptide regulation (not legal advice).
- Evidence grading methodology — how we grade claims and why.
- Medical disclaimer — what this site is and is not.